Peripheral vasculopathy in patients with systemic sclerosis: Difference in limited and diffuse subset of disease

Clinical Hemorheology and Microcirculation

Volumn 31, Issue 4, 2004, Pages 281-285

  Ostojić, Predrag ^a   Damjanov, Nemanja ^a   Pavlov Dolijanovic, Slavica ^a   Radunović, Goran ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD VESSEL INJURY; CAPILLAROSCOPY; CAPILLARY; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FINGER TIP INJURY; HUMAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; PERIPHERAL VASCULAR DISEASE; RANK SUM TEST; RAYNAUD PHENOMENON; SCAR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS; TELANGIECTASIA; ULCER; CLASSIFICATION; FINGER; MIDDLE AGED; PATHOLOGY; VASCULARIZATION;

CAPILLARIES; FINGERS; HUMANS; MIDDLE AGED; OSTEOLYSIS; PERIPHERAL VASCULAR DISEASES; SCLERODERMA, SYSTEMIC; TELANGIECTASIS; ULCER;

EID: 21444451250     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. J.R. Seibold, Scleroderma, in: Textbook of Rheumatology, W.N. Kelley, E.D. Harris, S. Ruddy, C.B. Sledge, eds, 5th edn, Saunders, Philadelphia, 1997, pp. 1133-1163.
2. C. Cervini and W. Grassi, Raynaud's phenomenon, Rheumatology in Europe 25(3) (1996), 111-113.
3. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum. 23 (1980), 581-590.
4. M. Giordano, G. Valentini, S. Migliaresi et al., Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis, J. Rheumatol. 13 (1986), 202-205.
5. N. Damjanov, Significance of capillaroscopic findings for the diagnosis of systemic sclerosis, Acta Rheum. Belgrad 15(1) (1995), 61-86.
6. C.P. Denton, M.C. Bickerstaff, X. Shiwen et al., Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis, Br. J. Rheumatol. 34 (1995), 1048-1054.
7. H. Ihn, S. Sato, M. Fujimoto et al., Increased serum levels of solubile vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis, Br. J. Rheumatol. 37 (1998), 1188-1192.
8. B. Kahleh, O. Meyer and R. Scorza, Assessment of vascular involvement, Clin. Exp. Rheumatol. 21(Suppl. 29) (2003), S9-S14.
9. M. Cutolo, A. Sulli, C. Pizzorni et al., Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis, J. Rheumatol. 27(1) (2000), 155-160.
10. S. Jacobsen, P. Halberg, S. Ullman et al., Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis, J. Rheumatol. 37 (1998), 39-45.
11. V.D. Steen, D.L. Powell and T.A. Medsger Jr., Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis, Arthritis Rheum. 31 (1988), 196-203.
12. M. Hariss and A. Rosen, Autoimmunity on scleroderma: the origin, pathogenetic role and clinical significance of autoantibodies, Curr. Opin. Rheumatol. 15(6) (2003), 778-784.